Commonwealth Retirement Investments’s AbbVie ABBV Stock Holding History

Commonwealth Retirement Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.1M	Buy	56,009 +1,938	+4%	+$417K	3.83%	2
2026 Q1	$11.8M	Buy	54,071 +1,979	+4%	+$439K	3.64%	3
2025 Q4	$11.9M	Sell	52,092 -1,099	-2%	-$250K	3.83%	3
2025 Q3	$12.3M	Buy	53,191 +895	+2%	+$182K	4.19%	3
2025 Q2	$9.71M	Buy	52,296 +2,267	+5%	+$421K	3.69%	4
2025 Q1	$10.5M	Buy	50,029 +1,140	+2%	+$222K	4.26%	3
2024 Q4	$8.69M	Buy	48,889 +1,346	+3%	+$247K	3.58%	4
2024 Q3	$9.39M	Buy	47,543 +510	+1%	+$95.2K	3.94%	4
2024 Q2	$8.07M	Buy	47,033 +2,150	+5%	+$356K	3.69%	6
2024 Q1	$8.17M	Buy	44,883 +1,668	+4%	+$287K	3.9%	6
2023 Q4	$6.7M	Buy	43,215 +626	+1%	+$91.3K	3.55%	6
2023 Q3	$6.35M	Buy	42,589 +1,734	+4%	+$255K	3.66%	8
2023 Q2	$5.5M	Buy	40,855 +5,391	+15%	+$791K	3.07%	11
2023 Q1	$5.65M	Buy	35,464 +9	+0%	+$1.38K	3.35%	11
2022 Q4	$5.73M	Buy	+35,455	New	+$5.44M	3.47%	11

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Commonwealth Retirement Investments's ABBV Position: Q2 2026 in Review

Commonwealth Retirement Investments increased its AbbVie (ABBV) stake by 3.6% in Q2 2026, buying an estimated $417K and bringing the position to 56,009 shares worth $14.1M. The position accounts for 3.83% of the portfolio, ranked #2.

Commonwealth Retirement Investments first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Commonwealth Retirement Investments held 56,009 shares of AbbVie worth $14.1M as of Q2 2026.
Commonwealth Retirement Investments bought 1,938 AbbVie shares in Q2 2026, an estimated $417K.
AbbVie made up 3.83% of Commonwealth Retirement Investments's portfolio in Q2 2026, its #2 holding.
Commonwealth Retirement Investments first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Commonwealth Retirement Investments's 13F filing for Q2 2026, filed 3 Aug 2026.